No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bortezomib / administration & dosage
-
Bridged Bicyclo Compounds, Heterocyclic / pharmacology
-
Bridged Bicyclo Compounds, Heterocyclic / therapeutic use*
-
Chromosomes, Human, Pair 11 / genetics
-
Chromosomes, Human, Pair 14 / genetics
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Dexamethasone / administration & dosage
-
Doxorubicin / administration & dosage
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Leukemia, Plasma Cell / complications
-
Leukemia, Plasma Cell / drug therapy*
-
Leukemia, Plasma Cell / genetics
-
Leukemia, Plasma Cell / therapy
-
Male
-
Middle Aged
-
Molecular Targeted Therapy*
-
Neoplasm Proteins / antagonists & inhibitors
-
Neoplasm, Residual
-
Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors
-
Recurrence
-
Sulfonamides / pharmacology
-
Sulfonamides / therapeutic use*
-
Translocation, Genetic
-
Vincristine / administration & dosage
Substances
-
Antineoplastic Agents
-
Bridged Bicyclo Compounds, Heterocyclic
-
Neoplasm Proteins
-
Proto-Oncogene Proteins c-bcl-2
-
Sulfonamides
-
Vincristine
-
Bortezomib
-
Dexamethasone
-
Doxorubicin
-
Cyclophosphamide
-
venetoclax